Argon News and Research

RSS

Effects of radiofrequency ablation and complete endoscopic resection are equal in dysplastic Barrett's esophagus

According to a new systematic review article, radiofrequency ablation and complete endoscopic resection are equally effective in the short-term treatment of dysplastic Barrett's esophagus, but adverse event rates are higher with complete endoscopic resection.

22 May 2014

Argon Medical Devices starts marketing CLEANERXT Rotational Thrombectomy System

Argon Medical Devices, Inc. announced today that the company has begun marketing the CLEANERXT Rotational Thrombectomy System as a new addition to the CLEANER family of dialysis products.

6 May 2014

Argon gets FDA clearance to market OptionELITE IVC filter over-the-wire delivery technique

Argon Medical Devices, Inc. announced today that the company has received clearance from the US Food and Drug Administration to begin marketing the OptionELITE retrievable inferior vena cava filter with a new over-the-wire delivery technique.

16 Jan 2014

Argon Medical Devices releases OptionELITE Retrievable Vena Cava Filter

Continuing our commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism, Argon Medical Devices, Inc. takes another step forward with the launch of the Option™ELITE Retrievable Vena Cava Filter.

4 Apr 2013

Researcher receives grant to enhance human tissue dissection, reduce blood transfusions during surgery

A George Washington University researcher recently received a grant to study ways to cut human tissue more efficiently, an effort that could minimize the need for blood transfusions and other products for patients during surgery.

27 Mar 2013

Special issue on colorectal cancer published in GIE: Gastrointestinal Endoscopy journal

In recognition of National Colorectal Cancer Awareness Month, GIE: Gastrointestinal Endoscopy has published a special issue for March on colorectal cancer.

20 Mar 2013

Paper says hospitals that do treat patients with anemia have better outcomes

Up to one-third of patients undergoing surgery in Ontario have a treatable form of anemia but are not optimally treated for it.

28 Jan 2013

Argon Medical to launch Cleaner15 technology for mechanical thrombectomy procedures

Furthering its commitment to advancing the treatment of patients diagnosed with ESRD (End Stage Renal Disease), Argon Medical Devices, Inc. takes another leap forward with the launch of the Cleaner15 Rotational Thrombectomy System.

17 Jan 2013

Percutaneous cryoablation freezes and destroys breast cancer tumors

Individuals fighting metastatic breast cancer, where the disease has progressed to other areas of the body, may finally have another weapon in their arsenal: percutaneous cryoablation.

26 Mar 2012

Low-temperature plasmas can kill bacteria for a week after treatment

University of California, Berkeley, scientists have shown that ionized plasmas like those in neon lights and plasma TVs not only can sterilize water, but make it antimicrobial - able to kill bacteria - for as long as a week after treatment.

16 Nov 2011

Customized surfaces help reveal protein clumping process linked with Alzheimer's, diabetes

When normal proteins form protein clumps in the body, then alarm bells start ringing. Such clumps, called "amyloids," are closely associated with Alzheimer's disease and type 2 diabetes, formerly called adult-onset diabetes.

29 Jul 2011

Multipolar electrocoagulation is a safe, effective therapy for Barrett's esophagus

A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett's esophagus over the long term.

26 Apr 2011

Argon acquires global rights to market, distribute Rex Medical's Option Retrievable Inferior Vena Cava Filter

Argon Medical Devices, Inc. announced today that it has entered into a definitive license agreement with Rex Medical, LP ("Rex Medical") for exclusive global rights to market and distribute the Option™ Retrievable Inferior Vena Cava Filter, an implantable device used in the prevention of Pulmonary Embolism (PE).

15 Mar 2011

Argon enters licensing agreement with Rex Medical for UltraStream catheter

Argon Medical Devices, Inc. announced today that it has entered into a definitive licensing agreement with Rex Medical, LP for exclusive rights to market and distribute the UltraStream chronic dialysis catheter on a global basis.

16 Nov 2010

Pen-size plasma sterilization device

Prof. Jiunn-Der Liao of Department of Materials Science and Engineering at National Cheng Kung University (NCKU), Tainan, Taiwan, has led Post Doctorate Chih-Chiang Weng and a research team to develop a pen-size plasma sterilization device which can sterilize instruments and wounds by relying on the process of plasma sterilization.

25 Aug 2010

Praxair increases prices of gases and facility fees

Praxair, Inc. and Praxair Canada Inc. are notifying bulk and packaged industrial and medical gas customers in the United States and Canada of the following increases in product prices, facility fees/monthly basic charges and other items, effective September 1, 2010, or as contracts permit:

16 Aug 2010

WPI's workshop to include demonstrations on location, tracking and physiological monitoring systems

Worcester Polytechnic Institute, a leader in the development of technology for precisely locating, tracking, and monitoring first responders inside buildings, will host the fifth annual Workshop on Precision Indoor Personnel Location and Tracking Technology for Emergency Responders in the WPI Campus Center Aug. 2-3, 2010.

22 Jul 2010

Biomagnetics Diagnostics reports positive test results of unique PVA film formulation

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the results of recent testing of the unique PVA film formulation produced by Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. Earlier this week, Biomagnetics announced its intent to acquire Lanzhou as the first of several planned acquisitions to be done at a $1.00 share price valuation for Biomagnetics Diagnostics' common shares.

15 Jul 2010

MicroPulse protocol as effective as ETDRS in treatment of DME: Study

IRIDEX Corporation announced the recent publication of a clinical study comparing results obtained in the treatment of diabetic macular edema (DME) using an IRIDEX laser and MicroPulse™ treatment protocol to those obtained using the recognized standard of care Early Treatment of Diabetic Retinopathy Study (ETDRS) laser protocol.

17 Jun 2010

BD to sell certain assets of Medical segment

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has signed agreements to sell certain assets of its BD Medical segment, including the Ophthalmic Systems unit as well as the surgical blades, critical care and extended dwell catheter product platforms of the Medical Surgical Systems unit.

From BD (Becton, Dickinson and Company) 8 Jun 2010